ATE283852T1 - Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen - Google Patents
Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasenInfo
- Publication number
- ATE283852T1 ATE283852T1 AT02706711T AT02706711T ATE283852T1 AT E283852 T1 ATE283852 T1 AT E283852T1 AT 02706711 T AT02706711 T AT 02706711T AT 02706711 T AT02706711 T AT 02706711T AT E283852 T1 ATE283852 T1 AT E283852T1
- Authority
- AT
- Austria
- Prior art keywords
- naphthostyril
- cyclin
- inhibitors
- derivatives
- dependent kinases
- Prior art date
Links
- GPYLCFQEKPUWLD-UHFFFAOYSA-N 1h-benzo[cd]indol-2-one Chemical class C1=CC(C(=O)N2)=C3C2=CC=CC3=C1 GPYLCFQEKPUWLD-UHFFFAOYSA-N 0.000 title 1
- 108091007914 CDKs Proteins 0.000 title 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 title 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26365801P | 2001-01-23 | 2001-01-23 | |
| PCT/EP2002/000366 WO2002059109A2 (en) | 2001-01-23 | 2002-01-16 | Naphthostyril derivatives and their use as inhibitors of cyclin- dependent kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE283852T1 true ATE283852T1 (de) | 2004-12-15 |
Family
ID=23002712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02706711T ATE283852T1 (de) | 2001-01-23 | 2002-01-16 | Naphthostyril derivate und deren verwendung als inhibitoren von cyclin-abhängigen kinasen |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6504034B2 (de) |
| EP (1) | EP1358180B1 (de) |
| JP (1) | JP4091434B2 (de) |
| KR (1) | KR100563429B1 (de) |
| CN (1) | CN1231479C (de) |
| AR (1) | AR035738A1 (de) |
| AT (1) | ATE283852T1 (de) |
| AU (1) | AU2002240905B2 (de) |
| BR (1) | BR0206621A (de) |
| CA (1) | CA2434381C (de) |
| DE (1) | DE60202131T2 (de) |
| ES (1) | ES2232736T3 (de) |
| MX (1) | MXPA03006423A (de) |
| PE (1) | PE20020916A1 (de) |
| UY (1) | UY27132A1 (de) |
| WO (1) | WO2002059109A2 (de) |
| ZA (1) | ZA200305383B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009263037B2 (en) * | 2008-06-26 | 2011-10-06 | Amgen Inc. | Alkynyl alcohols as kinase inhibitors |
| CN109665987B (zh) * | 2018-12-28 | 2022-02-18 | 河南大学 | 萘内酰亚胺-多胺缀合物及其制备方法和用途 |
| KR102947433B1 (ko) | 2019-04-12 | 2026-04-06 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스 및 아이올로스의 트리시클릭 분해제 |
| JP7863100B2 (ja) * | 2020-10-14 | 2026-05-20 | シーフォー セラピューティクス， インコーポレイテッド | Ｉｋｚｆ２又はｉｋｚｆ４を分解する三環式リガンド |
| CA3217792A1 (en) | 2021-05-07 | 2022-11-10 | Kymera Therapeutics, Inc | Cdk2 degraders and uses thereof |
| JP2025505687A (ja) * | 2022-02-09 | 2025-02-28 | シーフォー セラピューティクス， インコーポレイテッド | Ｃｆｔ７４５５のモルフィック形態及びその製造方法 |
| WO2026024674A1 (en) | 2024-07-22 | 2026-01-29 | Genesis Therapeutics, Inc. | Methods of treating skp2-associated cancers |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5081131A (en) * | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| CA2037923C (en) | 1989-07-25 | 1996-08-06 | Taiho Pharmaceutical Co., Ltd. | Oxindole derivative |
| WO1992007830A2 (en) | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
| FR2694004B1 (fr) | 1992-07-21 | 1994-08-26 | Adir | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. |
| GB9313638D0 (en) | 1993-07-01 | 1993-08-18 | Erba Carlo Spa | Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
| GB9423997D0 (en) | 1994-11-28 | 1995-01-11 | Erba Carlo Spa | Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation |
| GB9501567D0 (en) | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| GB9507298D0 (en) | 1995-04-07 | 1995-05-31 | Pharmacia Spa | Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors |
| US5880141A (en) | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
| DE29513441U1 (de) | 1995-08-22 | 1995-10-19 | Engelhardt, Rolf, 45883 Gelsenkirchen | Aschenbecher zum Mitführen |
| EP0929520B1 (de) | 1996-08-23 | 2005-11-02 | Sugen, Inc. | Kombinatorische bibliotheken von indolinone und verwandte produkte und verfahren zur behandlung von krankheiten |
| US5750556A (en) * | 1996-10-30 | 1998-05-12 | American Home Products Corporation | 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano- 2,3-E!indol-8-ones and derivatives |
| CA2289102A1 (en) | 1997-05-07 | 1998-11-12 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
| DE69906152T2 (de) | 1998-12-17 | 2004-02-12 | F. Hoffmann-La Roche Ag | 4-alkenyl (und alkinyl)oxoindole als inhibitoren cyclinabhängiger kinasen, insbesondere cdk2 |
-
2002
- 2002-01-10 US US10/043,732 patent/US6504034B2/en not_active Expired - Fee Related
- 2002-01-16 CA CA002434381A patent/CA2434381C/en not_active Expired - Fee Related
- 2002-01-16 JP JP2002559411A patent/JP4091434B2/ja not_active Expired - Fee Related
- 2002-01-16 DE DE60202131T patent/DE60202131T2/de not_active Expired - Lifetime
- 2002-01-16 AT AT02706711T patent/ATE283852T1/de not_active IP Right Cessation
- 2002-01-16 AU AU2002240905A patent/AU2002240905B2/en not_active Ceased
- 2002-01-16 MX MXPA03006423A patent/MXPA03006423A/es active IP Right Grant
- 2002-01-16 CN CNB028040406A patent/CN1231479C/zh not_active Expired - Fee Related
- 2002-01-16 WO PCT/EP2002/000366 patent/WO2002059109A2/en not_active Ceased
- 2002-01-16 EP EP02706711A patent/EP1358180B1/de not_active Expired - Lifetime
- 2002-01-16 ES ES02706711T patent/ES2232736T3/es not_active Expired - Lifetime
- 2002-01-16 KR KR1020037009680A patent/KR100563429B1/ko not_active Expired - Fee Related
- 2002-01-16 BR BR0206621-1A patent/BR0206621A/pt not_active IP Right Cessation
- 2002-01-21 AR ARP020100201A patent/AR035738A1/es not_active Application Discontinuation
- 2002-01-22 UY UY27132A patent/UY27132A1/es not_active Application Discontinuation
- 2002-01-22 PE PE2002000045A patent/PE20020916A1/es not_active Application Discontinuation
- 2002-08-20 US US10/224,022 patent/US6531598B1/en not_active Expired - Fee Related
-
2003
- 2003-07-11 ZA ZA200305383A patent/ZA200305383B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE60202131D1 (de) | 2005-01-05 |
| KR20030069223A (ko) | 2003-08-25 |
| ES2232736T3 (es) | 2005-06-01 |
| EP1358180B1 (de) | 2004-12-01 |
| CN1231479C (zh) | 2005-12-14 |
| PE20020916A1 (es) | 2002-10-21 |
| US6504034B2 (en) | 2003-01-07 |
| KR100563429B1 (ko) | 2006-03-22 |
| CA2434381A1 (en) | 2002-08-01 |
| ZA200305383B (en) | 2004-10-11 |
| CN1487931A (zh) | 2004-04-07 |
| WO2002059109A2 (en) | 2002-08-01 |
| US20020147343A1 (en) | 2002-10-10 |
| AR035738A1 (es) | 2004-07-07 |
| US6531598B1 (en) | 2003-03-11 |
| BR0206621A (pt) | 2004-02-25 |
| MXPA03006423A (es) | 2003-10-15 |
| JP4091434B2 (ja) | 2008-05-28 |
| EP1358180A2 (de) | 2003-11-05 |
| CA2434381C (en) | 2009-11-24 |
| UY27132A1 (es) | 2002-07-31 |
| AU2002240905B2 (en) | 2007-03-01 |
| WO2002059109A3 (en) | 2002-09-19 |
| JP2004517150A (ja) | 2004-06-10 |
| DE60202131T2 (de) | 2005-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325761D1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
| ATE367381T1 (de) | Neue spirotricyclische derivate und deren verwendung als phosphodiesterase-7-inhibitoren | |
| ATE315554T1 (de) | Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren | |
| ATE332896T1 (de) | 4-aminothiazol derivate, deren herstellung und deren verwendung als inhibitoren cyclin- abhängiger kinasen | |
| ATE394102T1 (de) | Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren | |
| DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
| DE60221886D1 (de) | 3-cyanochinoline als inhibitoren von egf-r- und her2-kinasen | |
| DE60321808D1 (de) | Flavon derivate als inhibitoren von cyclin-abhängigen kinasen | |
| CY2011016I1 (el) | Λακταμουχες ενωσεις και παραγωγα αυτων ως αναστολεις του παραγοντα χα | |
| DE60121595D1 (de) | Mannich base prodrugs von 3-(pyrrol-2-ylmethylidene)-2-indolinon derivate und deren verwendung als protein kinase inhibitoren | |
| DE60113719D1 (de) | Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten | |
| DE60234167D1 (de) | Bipiperidin-derivate und ihre verwendung als inhibitoren der chemokinrezeptoren | |
| ATE299881T1 (de) | 4-substituierte 7-aza-indolin-2-one und ihre anwendung als protein kinase inhibitoren | |
| ATE338547T1 (de) | Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren | |
| DE60208351D1 (de) | Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung | |
| DE60020100D1 (de) | Dimerverbindungen und als inhibitoren der neuramidinase | |
| ATE414699T1 (de) | Inhibitoren von tyrosinkinasen | |
| ATE521598T1 (de) | 5-phenylthiazol-derivate und ihre verwendung als pi3 kinase inhibitoren | |
| DE60223841D1 (de) | Medizinische verwendung von gsk3-hemmenden oxindolderivaten | |
| EE200300491A (et) | 6-asendis asendatud indolinoonid ja nende kasutamine kinaas-inhibiitoritena | |
| ATE308323T1 (de) | Diaminothiazole und ihre anwendung als cdk4 inhibitoren | |
| ATE382040T1 (de) | Acylaminothiazolderivate und ihre vewrendung als beta-amyloid inhibitoren | |
| DE60336720D1 (de) | Fluorsulfate von hexafluorisobutylen und dessen höheren homologen und deren derivaten | |
| ATE499096T1 (de) | Kombination von serotonin-wiederaufnahme-hemmern und agomelatin | |
| DE60309344D1 (de) | Derivate von ä6, 7-dihydro -5h-imidazoä1,2 - aüimidazol -3 -sulfonylaminoü-propionamid und deren verwendung als inhibitoren der interaktion von cams und leukointreginen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1358180 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |